Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry

Background Ticagrelor is a P2Y12 receptor inhibitor with superior clinical efficacy compared with clopidogrel. However, it is associated with reduced efficacy when combined with a high‐dose aspirin. Methods and Results Patients in the acute coronary treatment and intervention outcomes network (ACTIO...

Full description

Bibliographic Details
Main Authors: Sukhdeep S. Basra, Tracy Y. Wang, DaJuanicia N. Simon, Karen Chiswell, Salim S. Virani, Mahboob Alam, Vijay Nambi, Ali E. Denktas, Anita Deswal, Biykem Bozkurt, Christie M. Ballantyne, Eric D. Peterson, Hani Jneid
Format: Article
Language:English
Published: Wiley 2018-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute myocardial infarction
aspirin
clopidogrel
P2Y12
prasugrel
ticagrelor
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.008125

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.008125

Similar Items